Domů › Akutní myeloidní leukemie › Kalifornie › Baldwin Park
Klinické studie Akutní myeloidní leukemie v Baldwin Park, CA
40 studií pro Akutní myeloidní leukemie hledá účastníky v lokalitách v Baldwin Park a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Probíhá náborFáze 2/3
- City of Hope National Medical Center /ID# 279568, Duarte · Vzdálenost 4 mi
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Probíhá náborFáze 1
- City of Hope, Duarte · Vzdálenost 4 mi
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Probíhá náborFáze 1
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Probíhá náborFáze 3
- Clinical Trial Site, Duarte · Vzdálenost 4 mi
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Probíhá náborFáze 3
- City of Hope, Duarte · Vzdálenost 4 mi
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Probíhá náborFáze 3
- City of Hope Comprehensive Cancer Center, Duarte · Vzdálenost 4 mi
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Probíhá náborFáze 2
- City of Hope Comprehensive Cancer Center, Duarte · Vzdálenost 4 mi
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Probíhá náborFáze 1
- City of Hope National Medical Center, Duarte · Vzdálenost 4 mi
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Probíhá náborFáze 1/2Vítáni zdraví dobrovolníci
- City of Hope, Duarte · Vzdálenost 4 mi
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Probíhá náborFáze 1/2
- City of Hope Comprehensive Cancer Center, Duarte · Vzdálenost 4 mi
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Probíhá náborFáze 1/2
- City of Hope National Medical Center, Duarte · Vzdálenost 4 mi
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Probíhá náborFáze 1
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Probíhá náborFáze 1
- City of Hope, Duarte · Vzdálenost 4 mi
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
Probíhá náborFáze 1
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
Individualized AML Treatment
Probíhá náborObservační studie
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Probíhá náborFáze 2
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Probíhá náborFáze 1
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Probíhá náborFáze 1Vítáni zdraví dobrovolníci
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Probíhá náborFáze 3
- City of Hope Comprehensive Cancer Center - Duarte, Duarte · Vzdálenost 4 mi
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
Probíhá náborFáze 1
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Probíhá náborObservační studie
- City of Hope, Duarte · Vzdálenost 4 mi
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Probíhá náborFáze 1
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Probíhá náborFáze 2
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
A Study of Revumenib and Mezigdomide in People With Leukemia
Probíhá náborFáze 1/2
- City of Hope Cancer Center (Data collection only), Duarte · Vzdálenost 4 mi
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Probíhá náborFáze 1
- City of Hope, Duarte · Vzdálenost 4 mi
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Probíhá náborFáze 1Vítáni zdraví dobrovolníci
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Probíhá náborFáze 1
- City of Hope, Duarte · Vzdálenost 4 mi
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Probíhá náborFáze 1
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Probíhá náborFáze 2
- City of Hope, Duarte · Vzdálenost 4 mi
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Probíhá náborFáze 1
- City of Hope, Duarte · Vzdálenost 4 mi
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Probíhá náborFáze 2Vítáni zdraví dobrovolníci
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Probíhá náborFáze 1
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
Probíhá náborFáze 1
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Probíhá náborFáze 1
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Probíhá náborFáze 1
- City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte · Vzdálenost 4 mi
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Probíhá náborFáze 2
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
Probíhá náborFáze 1
- City of Hope - Duarte, Duarte · Vzdálenost 4 mi
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Probíhá náborFáze 1
- City of Hope Medical Center, Duarte · Vzdálenost 4 mi
Study of REM-422 in Patients With AML or Higher Risk MDS
Probíhá náborFáze 1
- City of Hope, Duarte · Vzdálenost 4 mi
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Probíhá náborFáze 1
- City of Hope National Medical Center, Duarte · Vzdálenost 4 mi
Studie Akutní myeloidní leukemie v jiných městech
- Houston, TX85 studií
- New York City, NY51 studií
- Boston, MA44 studií
- Seattle, WA41 studií
- Columbus, OH35 studií
- Philadelphia, PA34 studií
- Durham, NC33 studií
- Atlanta, GA31 studií
- Tampa, FL29 studií
- Chicago, IL26 studií
- Portland, OR25 studií
- Washington, DC24 studií
Další studie v Baldwin Park
- Rakovina prsu44 studií
- Kolorektální karcinom37 studií
- Nemalobuněčný plicní karcinom36 studií
- Rakovina (všechny typy)34 studií
- Rakovina prostaty30 studií
- Metastatický karcinom30 studií
- Myelodysplastické syndromy26 studií
- Rakovina vaječníků25 studií
- Rakovina plic24 studií
- Mnohočetný myelom23 studií
- Rakovina žaludku22 studií
- Akutní lymfoblastická leukemie21 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.